Joel White

TL;DR: Five patients relapsed in the brain, all associated with chest failure, and quality control analysis, including dosimetric reconstruction and port film review was introduced after the protocol was activated and was retrospectively applied.

TL;DR: Although not statistically significant, the survival and response rates of patients in the combined levamisole arms were shorter than those of patients with limited squamous cell carcinoma of the lung in the combination of chemotherapy, immunotherapy, and performance status.

TL;DR: The authors conclude that the addition of late consolidative radiation therapy to induction chemotherapy in the treatment of limited‐stage SCLC is well tolerated and improves local control, but does not improve time to progression or rates of survival.

TL;DR: It appears that BCG immunotherapy has no beneficial effect on response rate, duration of response, or survival in programs using chemotherapy and radiotherapy for control of limited small‐cell carcinoma of the lung except in this small group of long‐term survivors.

TL;DR: In patients with extensive disease only 6 of 152 prophylactically irradiated patients developed CNS signs or symptoms of CNS recurrence and in only 4 was this the site of initial failure.